Items

• How would you treat: glucagon-like peptide 1 receptor analogue or sodium-glucosecotransporter 2 inhibitor in chronic coronary syndrome and heart failure in type 2diabetes? (2020-02)

  Kovacevic Preradovic T, Zivanovic Z, Stanetic B, Kos L, Sobot N, Stojakovic S, Uncanin D, How would you treat: glucagon-like peptide 1 receptor analogue or sodium-glucosecotransporter 2 inhibitor in chronic coronary syndrome and heart failure in type 2diabetes?, Srce i krvni sudovi, Vol. 39, No. 1, pp. 8 - 10, Feb, 2020

• Effective therapeutic strategies for diabetic cardiomyopathy. (2021-06)

  Kovacevic Preradovic T, Stanetic B, Zivanović Z, Kos L, Sobot N, Stojkovic S, Uncanin D, Effective therapeutic strategies for diabetic cardiomyopathy., Srce i krvni sudovi, Vol. 40, No. 1, pp. 5 - 7, Jun, 2021